First-Line Treatment of IDA in NDD-CKD

This promotional article was developed in conjunction with and sponsored by Daiichi Sankyo, Inc.


Read Now

In this supplement to Internal Medicine News , Kamyar Kalantar-Zadeh, MD, MPH, PhD, discusses a first-line treatment option for iron deficiency anemia (IDA) in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). Topics include:

  • The interplay between IDA and CKD
  • Recognizing IDA in patients with CKD
  • First-line treatment efficacy and safety information

Read Now

Next Article: